Monday, June 08, 2026

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Spike Protein from mRNA COVID Shots Detected in Placenta and Fetal Cells

Spike Protein from mRNA COVID Shots Detected in Placenta and Fetal Cells

A new peer-reviewed study has found spike protein and vaccine-derived mRNA in human placental tissue and fetal immune cells, including in mothers who were vaccinated before pregnancy and had no documented SARS-CoV-2 infection. The study, published Mar. 5, 2026 in PLOS One, analyzed 106 placentas from women who delivered between 2020 and 2022 and used […]

Moderna’s mNEXSPIKE mRNA COVID-19 Shot Approved by European Commission

Moderna’s mNEXSPIKE mRNA COVID-19 Shot Approved by European Commission

The European Commission (EC) has granted marketing authorization for Moderna’s mNEXSPIKE mRNA COVID-19 shot, allowing it to be marketed across the European Union (U.N.). The authorization follows a regulatory review and permits all 27 E.U. Member States, as well as Iceland, Liechtenstein and Norway, to consider the shot for use within their vaccination programs. It […]

Combination mRNA COVID-Influenza Shot Recommended by European Medicines Agency

Combination mRNA COVID-Influenza Shot Recommended by European Medicines Agency

The European Medicine Agency (EDA) has recommended marketing authorization for Moderna’s mCombriax mRNA (messenger ribonucleic acid) shot. The product, also known as mRNA-1083, is a genetically engineered biologic targeting both influenza and COVID-19. It builds on work Moderna has done on its next-generation mRNA COVID shot known as mNexSpike and mRNA-1010.1 2 3 The recommendation […]

FDA Greenlights Review of Moderna’s mRNA Flu Shot After Application Amended

FDA Greenlights Review of Moderna’s mRNA Flu Shot After Application Amended

On Feb. 18, 2026, the U.S. Food and Drug Administration (FDA) agreed to review Moderna’s application for its mRNA influenza shot, known as mRNA-1010, after the company amended its submission to address regulatory concerns. The agency accepted the updated biologics license application and set a target action date of Aug. 5, 2026, allowing the shot […]

Injured Former Chicago Baseball Prospect Sues Team and League Over COVID-19 Shot

Injured Former Chicago Baseball Prospect Sues Team and League Over COVID-19 Shot

Isaiah Carranza, a former Chicago White Sox minor and major league pitching prospect has filed a lawsuit asserting that the White Sox and Major League Baseball (MLB) coerced him into receiving a COVID-19 shot in 2021, an injection which caused adverse reactions severe enough to end his baseball career. The federal lawsuit, which was filed […]

U.S. Researcher Wins $1.9 Million USDA Grant to Develop Novel Bird Flu Vaccine

U.S. Researcher Wins .9 Million USDA Grant to Develop Novel Bird Flu Vaccine

The U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) has awarded a three-year, $1.9 million grant to a researcher at the University of Missouri School of Medicine and the College of Veterinary Medicine to develop a novel vaccine against highly pathogenic avian influenza (HPAI) (“bird flu”) and Newcastle disease—another fatal, viral […]

Search in Site

To search in site, type your keyword and hit enter

Search